CompanyDrug

Ascletis Pharma’s COVID-19 Drug Candidate ASC11 Accepted for Review by NMPA

CompanyDeals

Hangzhou Polymed Biopharmaceuticals Raises Funds for Clinical Pipeline

CompanyDeals

Fosun Pharma Weighs Sale of India’s Gland Pharma Amid Market Interest

CompanyDeals

Fosun Pharma’s Gland Pharma to Acquire French CDMO Cenexi for EUR 120 Million

CompanyDrug

Luye Pharma Initiates Phase II Study for LY 03014 in China

Policy / Regulatory

China’s Drug-Eluting Stent Procurement Results Announced

CompanyDeals

Zhejiang Jiuzhou Pharma to Raise RMB 2.5 Billion via Private Placement

CompanyDeals

Frontier Biotechnologies Partners with CASAPC for AIDS Prevention in China

CompanyDrug

Henlius Completes First Dosing in Head-to-Head Study of PD-1 Inhibitor HanSiZhuang

CompanyDeals

JancsiTech Raises Tens of Millions in Angel Round Led by Yuanbio Venture Capital

CompanyDrug

FDA Rejects Spectrum’s Poziotinib NDA for NSCLC Treatment

Company

Sino Biological to Invest RMB 1 Billion in Beijing Bio-Pharmaceutical Park